These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24024678)

  • 41. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
    Göransson AM; Kolari PJ; Mustakallio KK
    Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study.
    Leonardi C; Sobell JM; Crowley JJ; Mrowietz U; Bao Y; Mulani PM; Gu Y; Okun MM
    Br J Dermatol; 2012 Sep; 167(3):658-67. PubMed ID: 22564148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dithranol: An Insight into its Novel Delivery Cargos for Psoriasis Management.
    Kadian V; Kumar S; Saini K; Kakkar V; Rao R
    Curr Drug Res Rev; 2020; 12(2):82-96. PubMed ID: 32484107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
    Lecha M; Mirada A; López S; Artés M;
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An open, parallel groups, study of the importance of thoroughness of application in the treatment of psoriasis with a dithranol cream (Micanol).
    Mørk NJ; Austad J; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1992; 172():23-4. PubMed ID: 1585758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Psoriasis: the clinical use of "minute therapy" with Cignolin].
    Runne U; Kunze J
    Z Hautkr; 1983 Feb; 58(4):219-29. PubMed ID: 6845794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial experience with routine administration of etanercept in psoriasis.
    de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
    Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-duration ('minutes') therapy with dithranol for psoriasis: a new out-patient regimen.
    Runne U; Kunze J
    Br J Dermatol; 1982 Feb; 106(2):135-9. PubMed ID: 7059509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S; Krishna V; Kanwar AJ
    Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
    Spuls PI; Hooft L
    Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness analysis of a psoriasis care instruction programme with dithranol compared with UVB phototherapy and inpatient dithranol treatment.
    Hartman M; Prins M; Swinkels OQ; Severens JL; De Boo T; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
    Br J Dermatol; 2002 Sep; 147(3):538-44. PubMed ID: 12207597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of treatment on quality of life in psoriasis patients.
    Prins M; Krabbe PF; Swinkels QO; de Boo T; van de Kerkhof PC; van der Valk PG
    Acta Derm Venereol; 2005; 85(4):304-10. PubMed ID: 16191850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short- and long-contact therapy using a new dithranol formulation in individually adjusted dosages in the management of psoriasis.
    Thune P; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1992; 172():28-9. PubMed ID: 1585760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ditrastick combined with UVB. An alternative regimen for plaque psoriasis.
    Brandt H
    Acta Derm Venereol Suppl (Stockh); 1989; 146():102-3. PubMed ID: 2609849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Experiences in half-side treatment with tar additive to cignolin-salicylic-acid-white-vaseline therapy of psoriasis vulgaris].
    Schulze HJ; Steigleder GK
    Z Hautkr; 1984 May; 59(10):654-6. PubMed ID: 6741204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.
    Fonia A; Jackson K; Lereun C; Grant DM; Barker JN; Smith CH
    Br J Dermatol; 2010 Oct; 163(4):807-16. PubMed ID: 20662837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methotrexate in pediatric plaque-type psoriasis: Long-term daily clinical practice results from the Child-CAPTURE registry.
    van Geel MJ; Oostveen AM; Hoppenreijs EP; Hendriks JC; van de Kerkhof PC; de Jong EM; Seyger MM
    J Dermatolog Treat; 2015 Oct; 26(5):406-12. PubMed ID: 25485870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidermal calmodulin levels in psoriasis before & after therapy.
    Kaur I; Kaur S; Vaishnavi C; Ganguly NK; Garg J; Kohli M
    Indian J Med Res; 1991 Apr; 94():130-3. PubMed ID: 1879887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Classical topical therapy of psoriasis].
    Gerdes S; Mrowietz U
    Hautarzt; 2006 Aug; 57(8):666-71. PubMed ID: 16841204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris.
    Darley CR; Cunliffe WJ; Green CM; Hutchinson PE; Klaber MR; Downes N
    Br J Dermatol; 1996 Sep; 135(3):390-3. PubMed ID: 8949431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.